U.S Class(es): 006, 018, 044, 046, 051, 052
| Name | Novartis Pharma AG, |
|---|---|
| Address | Trademark Department Postfach CH-4002 Basel SWITZERLAND |
| Date | Description | Action Tags | Code |
|---|---|---|---|
| Oct-19-2017 | SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB | SDRCM | |
| Oct-23-2017 | LIMITATION FROM ORIGINAL APPLICATION ENTERED | LIMII | |
| Oct-26-2017 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | NWOSI | |
| Oct-31-2017 | APPLICATION FILING RECEIPT MAILED | MAFRO | |
| Nov-02-2017 | ASSIGNED TO EXAMINER | DOCKD | |
| Nov-09-2017 | APPROVED FOR PUB - PRINCIPAL REGISTER | CNSAO | |
| Nov-29-2017 | NOTICE OF PUBLICATION | NPUBO | |
| Dec-19-2017 | PUBLISHED FOR OPPOSITION | PUBOA | |
| Mar-06-2018 | REGISTERED-PRINCIPAL REGISTER | R.PRA | |
| Apr-05-2018 | GRANT OF PROTECTION CREATED, TO BE SENT TO IB | GPARP | |
| Apr-13-2018 | FINAL DISPOSITION PROCESSED | FIMPP | |
| Apr-13-2018 | FINAL DISPOSITION NOTICE SENT TO IB | FICSP | |
| May-04-2018 | NOTIFICATION PROCESSED BY IB | GPNXP | |
| Jun-27-2021 | DEATH OF INTERNATIONAL REGISTRATION | DETHP | |
| Jun-27-2021 | NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED | DENCO | |
| Jun-12-2022 | NOTIFICATION PROCESSED BY IB | GPNXP | |
| Mar-08-2024 | INTERNATIONAL REGISTRATION RENEWED | RNWLP |